Bal Pharma Allots 10 Lakh Warrants to Promoter for ₹8.4 Cr

Bal Pharma Ltd has confirmed the allotment of 10,00,000 convertible warrants on a preferential basis to Mr. Shailesh Siroya, a promoter. The total issue size is ₹8.40 crore, with an issue price of ₹84 per warrant. The company has received 25% of the total amount, amounting to ₹2.10 crore. These warrants are convertible into equity shares within 18 months from the allotment date of September 7, 2026. The allotment does not change the company's paid-up equity share capital currently. Upon conversion, the new shares will rank pari passu with existing shares and will be listed on the stock exchanges.